Yunnan Baiyao Group stock
Price history
+0.64% over the period1 year: from ¥56.04 (November 20, 2025) to ¥56.40 (November 20, 2026), +0.64%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | ¥56.40 |
| October 30, 2026 | ¥53.71 |
| September 30, 2026 | ¥50.44 |
| August 31, 2026 | ¥50.39 |
| July 31, 2026 | ¥52.86 |
| June 30, 2026 | ¥47.37 |
| May 29, 2026 | ¥49.94 |
| April 30, 2026 | ¥53.05 |
| March 31, 2026 | ¥54.86 |
| February 27, 2026 | ¥56.05 |
| January 30, 2026 | ¥55.61 |
| December 31, 2025 | ¥56.76 |
| November 28, 2025 | ¥56.06 |
| November 20, 2025 | ¥56.04 |
At a glance
The company
Sells pharmaceuticals, medicinal materials, health products and daily chemical products in China, including traditional Chinese medicine and medical devices
Latest results
Quarter to September 30, 2026 · EPS ¥0.75 (estimate ¥0.75)
Next event
TickerLandia's take on Yunnan Baiyao Group
- Cheaper than usual relative to earnings: P/E on the latest fiscal year 20 vs a median of 27 over its last 10 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 19 vs 29 (−32%) in a group of 11.
- Strong point: Dividend (89/100 in its group). Weak point: Profitability (31/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−3.09% from the 52-week high
Analysts · 11 analysts
Average target¥66.38+17.69% vs. price
Buy 10 · Hold 1 · Sell 0 · Buy
TickerLandia Fingerprint: Yunnan Baiyao Group
Compared with similar companies: very low risk, very high dividend, and very high financial strength.
Financials and price compared with 39 companies in the drug manufacturers - specialty & generic industry, worldwide. Momentum and risk compared with 1,074 Asia-Pacific stocks.
Priceaverage43
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 19.4 36 EV/EBITDA 17.4 60 Forward P/E 17.4 43 Price/book 2.50 42 Price/sales 2.35 33 Profitabilitylow31
How much it earns on revenue and capital.
Metric Value Position in group ROE 13.0% 42 ROA 5.5% 42 Gross margin 28.2% 9 Operating margin 11.2% 19 Net margin 12.1% 42 Earnings stabilityhigh75
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.0% 88 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 63 Growthaverage43
How fast revenue and earnings are growing.
Metric Value Position in group Average revenue growth (3 years) +4.12% 33 Revenue growth (year over year) +10.40% 47 Earnings growth (year over year) −1.80% 50 Financial strengthvery high82
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength · more cash than debt −1.82 88 Interest coverage 191.6 83 Debt/equitycounts in reverse: lower means more financial strength 0.01 93 Current ratio 2.52 65 Dividendvery high89
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 33 years 98 Payout ratio 90.1% 89 Dividend yield 2.8% 79 Market momentumstrong64
How the stock has moved compared with the market.
Metric Value Position in group 1-year return +0.64% 48 Distance from 200-day average +7.15% 80 Riskvery low6
How much the price swings.
Metric Value Position in group Volatility (60 days) 15.1% 1 Maximum drawdown (12 months) 18.1% 11
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Yunnan Baiyao Group is cheaper than in the past and cheaper than similar companies
On the latest fiscal year's earnings (2025), Yunnan Baiyao Group's P/E today is 19.5, below the median of its last 10 fiscal years (27.1; between 19.6 and 48.0 from 2016 to 2025). Yunnan Baiyao Group's P/E (trailing 12 months): 19.4, −32% against the median of a group of 11 similar companies (28.7).
Compared with 11 similar companies
| Metric | Yunnan Baiyao Group | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 19.4 | Middle | |
| Forward P/E | 17.4 | Low | |
| Operating margin | 11.2% | Low | |
| ROE | 13.0% | Middle | |
| Debt/equity | 0.01 | Low |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Yunnan Baiyao Group. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
¥10.37B
Latest quarter · Q3 2026
Net income
¥1.12B
Latest quarter · Q3 2026
Quarterly net margin
10.8%
Latest quarter · Q3 2026
Numbers and valuation
Full valuation- Market cap
- ¥100.63B
- P/E
- 19.4
- EPS
- ¥2.91
- Volume
- 11.99M
- Daily trading
- €77.42M
- Dividend yield
- 2.81%
- Last ex-dividend on April 30, 2026
How Yunnan Baiyao Group is changing
All resultsRevenue grew 4.7% a year on average over the last 5 years
Free cash flow equal to 76% of net income
Revenue has grown for 9 fiscal years in a row
Returns
Yunnan Baiyao Group returns with dividends
¥1,000 invested in Yunnan Baiyao Group 5 years ago, on November 22, 2021, would be worth ¥1,077 today with dividends reinvested: +7.73% in total, +1.50% per year. On price alone it would be ¥879 (−12.06%).
| Period | Yunnan Baiyao Group | ¥1,000 becomes |
|---|---|---|
| 1 month | +5.66% | ¥1,057 |
| 6 months | +11.07% | ¥1,111 |
| Year to date | −0.63% | ¥994 |
| 1 year | +5.80% | ¥1,058 |
| 3 years | +29.10% | ¥1,291 |
| 5 years | +7.73% | ¥1,077 |
| 10 years | +56.92% | ¥1,569 |
From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment
The chart in detail
Yunnan Baiyao Group: technical analysis
Yunnan Baiyao Group shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 50.9% below its all-time closing high (¥114.86, February 10, 2021).
- Trend
- No clear trend
- RSI (14 sessions)
- 69
- Between 30 and 70
- vs 200-session average
- +7.15%
Active signals
Golden cross: the 50-session average has crossed above the 200-session average.
since November 19, 2026
The last session opened more than 3% below the previous close.
Support and resistance
Price areas where Yunnan Baiyao Group has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistance¥57.47+1.90%4 touches, last on April 3, 2026
- Last price¥56.40
- Support¥56.15−0.44%3 touches, last on November 3, 2026
- Support¥55.19−2.15%4 touches, last on March 4, 2026
- Support¥54.23−3.85%3 touches, last on October 19, 2026
Volatility and risk
- Volatility (60 sessions, annualised)
- 15.1%
- Largest fall in the last year
- −18.10%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Yunnan Baiyao Group: seasonality
Average monthly price change over 33 years
Over the last 33 years, the strongest month for Yunnan Baiyao Group has been August: +4.16% on average, positive in 19 years out of 33. The weakest has been January: +0.05% on average, positive in 12 years out of 33. November, the current month, has been positive in 16 years out of 32 (+1.00% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +0.05% | −2.03% | 12 of 33 |
| February | +0.68% | +0.71% | 17 of 33 |
| March | +1.89% | +1.95% | 20 of 33 |
| April | +3.65% | +0.83% | 20 of 33 |
| May | +1.36% | +0.44% | 18 of 33 |
| June | +1.13% | −1.67% | 14 of 33 |
| July | +2.52% | +2.41% | 20 of 33 |
| August | +4.16% | +1.52% | 19 of 33 |
| September | +1.46% | +1.29% | 19 of 33 |
| October | +0.54% | 0.00% | 16 of 33 |
| November | +1.00% | +0.20% | 16 of 32 |
| December | +3.33% | +1.49% | 17 of 32 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Yunnan Baiyao Group and its competitors
Sales of pharmaceuticals form the core of the business, with the company also distributing medicinal materials, health products and daily chemical goods across China. Its traditional Chinese medicine range for pain management and anti-inflammation includes the Yunnan Baiyao aerosol, ointment and band-aid, while its portfolio extends to generic drugs and specialty medicines for cardiovascular health, respiratory ailments, gynecology and pediatrics. The group also makes medical devices and tea products and offers pharmaceutical supply chain services.
- Headquarters
- Kunming, China
- Employees
- 9,286
- Founded
- 1902
- Chief executive
- Ming Dong
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Yunnan Baiyao Group000538 | $15.07B | 11.2% | 19.4 | +11.07% |
| PharmaEssentia6446 | $15.94B | 38.4% | 74.1 | +54.65% |
| Laurus LabsLAURUSLABS | $14.13B | 24.1% | 97.8 | +68.58% |
| Shionogi4507 | $16.75B | 31.6% | 11.2 | +2.83% |
| Zydus LifesciencesZYDUSLIFE | $12.92B | 17.2% | 28.7 | +15.29% |
| CiplaCIPLA | $12.34B | 13.0% | 39.5 | +1.11% |
Same industry or related industries, similar size. Compare Yunnan Baiyao Group with its competitors · Full profile
